[A review of recent pharmacological therapeutic principles in hypertension].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009842:Oligopeptides / Q000627:therapeutic use; D013722:Teprotide
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002491:Central Nervous System Agents; D004338:Drug Combinations; D009842:Oligopeptides; D013722:Teprotide
Oversikt av nyare farmakologiska behandlingsprinciper vid högt blodtryck.